|
|
№3 (приложение) / 2023
|
|
Danilov A.N., Sotskova V.A., Shuldyakov A.A., Lyapina E.P., Kolokolov O.V.
HIV-infection and sexually transmitted infections: regional trends
|
№3 / 2022
|
|
Kapustin D.V., Krasnova E.I., Khalikov M.R., Pozdnyakova L.L., Khokhlova N.I., Maksimenko L.V., Ekushov V.E., Totmenin A.V., Gashnikova N.M.
Analysis of the prevalence of HIV-1 primary resistance to antiretroviral medicinal agents in Novosibirsk region
|
№3 / 2022
|
|
Veselova E.I., Karamov E.V., Kudlay D.A., Samoilova A.G., Kaminsky G.D.
Efficacy and safety of antiretroviral therapy in «naive» patients with late stage of HIV infection
|
№3 / 2022
|
|
Mazus A.I., Nagibina M.V., Bessarab T.P., Tsyganova E.V., Litvinova N.G., Belova E.G., Nabiullina D.R., Kesaeva M.Yu.
COVID-19/HIV co-infection: characteristics of patients in the Moscow megalopolis
|
№4 / 2021
|
|
R.G. Yapparov, D.A. Lioznov, E.Yu. Karnaukhova, T.L. Galankin, T.V. Antonova
Indicators of immunogenicity of influenza vaccine in HIV-infected patients seronegative to influenza virus
|
№2 / 2018
|
Русский
